Time to evolve: predicting engineered T cell-associated toxicity with next-generation models | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Review

Time to evolve: predicting engineered T cell-associated toxicity with next-generation models

Online download statistics by month:

Online download statistics by month: May 2022 to March 2024

	Abstract	Full	Pdf
May 2022	928	966	375
Jun 2022	557	585	273
Jul 2022	483	502	294
Aug 2022	562	586	235
Sep 2022	659	675	202
Oct 2022	526	548	147
Nov 2022	446	456	122
Dec 2022	289	300	88
Jan 2023	272	282	91
Feb 2023	307	324	130
Mar 2023	339	350	126
Apr 2023	295	302	107
May 2023	268	277	85
Jun 2023	266	272	80
Jul 2023	526	533	124
Aug 2023	238	244	65
Sep 2023	174	183	68
Oct 2023	238	248	95
Nov 2023	249	254	106
Dec 2023	173	178	53
Jan 2024	110	111	65
Feb 2024	207	209	63
Mar 2024	277	281	88
Total	8389	8666	3082